Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

57.03
+0.75001.33%
Volume:332.11K
Turnover:18.80M
Market Cap:1.69B
PE:-63.04
High:57.22
Open:55.83
Low:55.00
Close:56.28
52wk High:73.30
52wk Low:17.11
Shares:29.61M
Float Shares:21.05M
Volume Ratio:0.80
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9047
EPS(LYR):-0.4601
ROE:-114.55%
ROA:6.78%
PB:132.47
PE(LYR):-123.95

Loading ...

AnaptysBio price target lowered to $60 from $90 at UBS

TIPRANKS
·
Apr 21

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 21

AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge

MT Newswires Live
·
Apr 20

Anaptys Completes Separation of First Tracks Biotherapeutics and NOW Exclusively Manages GSK and Vanda Financial Collaborations

THOMSON REUTERS
·
Apr 20

AnaptysBio completes spin-off of First Tracks Biotherapeutics in corporate reorganization

Reuters
·
Apr 20

Trade Alert: Independent Director Of AnaptysBio John Schmid Has Sold Stock

Simply Wall St.
·
Apr 08

Assessing AnaptysBio (ANAB) Valuation After New Share Buyback Plan And Canceled Equity Offering

Simply Wall St.
·
Apr 06

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

TIPRANKS
·
Apr 04

AnaptysBio files Form 3 for director Susannah Gray, reporting no securities owned

Reuters
·
Apr 04

AnaptysBio director John P. Schmid disposes shares worth $1.1 million

Reuters
·
Apr 02

AnaptysBio Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Apr 01

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

AnaptysBio Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 30

AnaptysBio Spin Off Reshapes Risk Profile With New Royalty Focus

Simply Wall St.
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

BUZZ-AnaptysBio falls after board approves First Tracks Biotherapeutics spinoff

Reuters
·
Mar 27

AnaptysBio announces $100M share repurchase program

TIPRANKS
·
Mar 27

AnaptysBio; First Tracks Bio private placement raises $80 million at $13.81 per share

Reuters
·
Mar 27

BRIEF-Anaptys Announces $100 Million Stock Repurchase Plan And Provides A Business Update

Reuters
·
Mar 27

BRIEF-Anaptys Board Of Directors Approves Spin-Off Of First Tracks Biotherapeutics

Reuters
·
Mar 27